Archive for the ‘Pregnancy’ Category

FDA Fraud: Detection of Messenger RNA COVID “Vaccines” In Human Breast Milk – Why COVID Shots Should Be Banned For Pregnant Woman

Warnings of “vaccine” shedding were dismissed as “misinformation,” yet the following study proves conclusively that “vaccine” shedding is indeed very real and that mRNA is shed in breast milk affecting babies.

These data demonstrate for the first time to our knowledge the biodistribution of COVID-19 vaccine mRNA to mammary cells and the potential ability of tissue EVs to package the vaccine mRNA that can be transported to distant cells.

Little has been reported on lipid nanoparticle biodistribution and localization in human tissues after COVID-19 mRNA vaccination.

Despite that, the authors say the following, possibly to get their letter past the JAMA censors:

The sporadic presence and trace quantities of COVID-19 vaccine mRNA detected in EBM suggest that breastfeeding after COVID-19 mRNA vaccination is safe, particularly beyond 48 hours after vaccination.

Your first reading of the above sentence might suggest that the authors said “COVID-19 mRNA vaccination is safe”. But it is ominously qualified with “particularly beyond 48 hours after vaccination”, plainly meaning that breastfeeding within 48 hours after vaccination is NOT safe.  Source

Notice that the article’s conclusion contradicts the data.

Go here for a great article on how to read scientific papers.

Researchers must now become expert wordsmiths to couch their findings in order to get their work published.

https://jamanetwork.com/journals/jamapediatrics/article-abstract/2796427

Research Letter
September 26, 2022

Detection of Messenger RNA COVID-19 Vaccines in Human Breast Milk

JAMA Pediatr. Published online September 26, 2022. doi:10.1001/jamapediatrics.2022.3581

Vaccination is a cornerstone in fighting the COVID-19 pandemic. However, the initial messenger RNA (mRNA) vaccine clinical trials excluded several vulnerable groups, including young children and lactating individuals.1 The US Food and Drug Administration deferred the decision to authorize COVID-19 mRNA vaccines for infants younger than 6 months until more data are available because of the potential priming of the children’s immune responses that may alter their immunity.2 The Centers for Disease Control and Prevention recommends offering the COVID-19 mRNA vaccines to breastfeeding individuals,3 although the possible passage of vaccine mRNAs in breast milk resulting in infants’ exposure at younger than 6 months was not investigated. This study investigated whether the COVID-19 vaccine mRNA can be detected in the expressed breast milk (EBM) of lactating individuals receiving the vaccination within 6 months after delivery.

https://rumble.com/v1i147t-naomi-wolf-lays-out-the-case-for-banning-covid-vaccines-for-pregnant-women.html  Video Here (Approx. 8 Min)

Naomi Wolf Lays Out The Case For Banning Covid Vaccines For Pregnant Women

Published August 30, 2022

Steve Bannon: (00:00)

I want to bring in another fighter Naomi Wolf.  So Naomi, in probably the most important midterm election since the civil war, you got all this news now with new boosters, you’re doing research. I think you guys have 35 reports. You’ve got the two companies suing, you got Moderna suing them. Walk us through where are we in all this and how they talk about new boosters, they’re suing each other. Uh, you’ve got you’ve guys are, come from these reports. You’ve got a new one on, on, I, I think, uh, men’s fertility, where do we stand with all this?

Dr. Naomi Wolf: (00:35)

It’s it’s almost difficult to keep up with the new findings that back up, what you know is my belief that, um, these, these injections are intended or have the effect that no one’s stopping, who should be stopping of harming the American people. And more and more evidence is emerging that the harms are to reproduction. Um, and that the harms are very specifically 360 degrees to women’s, uh, ability to reproduce effectively or successfully. Um, and since I even last spoke with you, there’s been even more really disturbing evidence that, that I’d like to share with your audience if I may. And I do think it’s so important because, you know, as we’ve seen just in the last two weeks, legacy news outlets like associated press and the spectator are willing to, uh, hammer an immediately corrected math error immediately publicly corrected math error that one of our volunteers made, but they’re misdirecting or redirecting their audiences in a very dangerous way. Uh, that is really a disservice to their audiences away from what is emerging in multiple places from multiple databases, including elsewhere in the Pfizer documents as terrifying evidence of massive harms to female reproduction. So Cameron said, I could walk you through two new data points, uh, from our reports. Is that possible?

Steve Bannon: (02:02)

Yes. Go ahead. Go ahead. Ma’am

Dr. Naomi Wolf: (02:04)

Thank you so much. So, uh, one of them is, uh, Denver should have a very scary image. Um, and I’d appreciate it if your producer would post it, if not you, there it is. Oh my God. So that is ladies and gentlemen, that is a pregnant woman’s placenta. Um, and I’m gonna read, uh, Dr. James Thorpe’s description. It’s his image from a presentation he gave. Um, this is an ultrasound image of a third trimester placenta in a pregnant woman who received the Pfizer vaccine eight weeks prior. This is a typical pattern that is commonly seen by him. About eight weeks post Pfizer vaccine, the white areas surrounding the placenta lobes, also known as codons represent calcifications from significant inflammation. Typically this finding may be associated with significant growth slowing of the fetus. That is the pre-born baby reduced amniotic fluid volume, abnormal, fetal, fetal surveillance testing.

(03:07)
And then he goes on to describe what fetal surveillance testing should be and should do. And then he says the large dark area in the placental lobe on the right may consistent with a blood clot. So again, ladies and gentlemen, I don’t know how many of you, you know, have been pregnant, had babies, your wives or partners have had babies, but that is not what a sonogram looks like. That’s not what a placenta that’s healthy and normal looks like. Those are terrifying, uh, unnatural irregular classifications that Dr. Thorpe explains are related to inflammation and over and over again, the, the science that our experts are finding and that other independent good researchers like Dr. Corey, Dr. Uh, Malone, Dr. McDonough are, are finding is that these, uh, materials in the vaccines cause inflammation. Um, so when I was reading the description, again, there’s less volume of amniotic fluid, which of course the baby needs in order to develop normally, and anecdotally what we’re hearing from nurses.

(04:14)
And I don’t, I am not ashamed. Uh, you know, as for 35 years covering women’s health, women’s sexual health, women’s reproductive health with two giant best sellers about obstetrics and gynecology and female sexual response. Um, you know, I actually know what I’m talking about when there’s a problem with women and women’s health, especially things that are hard to talk about, like giving birth or menstruating, or, you know, menopause. You first get the signal from women telling their stories among themselves. And you also first get the signal from nurses talking among themselves. So anecdotes are important. And what we’re hearing is that nurses are saying they are inducing labor early, uh, with vaccinated moms because the babies, um, cuz not safe, cuz the placenta are compromised. And remember over and over on this show, I would say the lipid nanoparticles are traversing. Every membrane in the human body, the placenta is a membrane.

(05:13)
The placenta is the most sacred, important membrane God gave us in order to reproduce our species. And how do you have a placenta that is not compromised if these industrial fats, these lipid nanoparticles coded with polyethylene glyco are designed to cross the placental barrier and remember again and again, and this is all over social media today. Um, spokespeople here in Britain, in Europe, we’re saying to pregnant women, go ahead and get the injection, get the mRNA vaccine. It cannot cross the placenta. It can’t hurt your developing baby. They were lying. They were either ignorant and, and, and inflicting their ignorance on defenseless mothers and their innocent witnesses. We

Steve Bannon: (05:57)

We’ve only got a couple we’ve only got a couple minutes and I got to have you back on tomorrow morning. This is that important, but I got to ask you, were they lying or you think they just, in your professional opinion, misread the data?

Dr. Naomi Wolf: (06:09)

Well, it’s, it’s impossible to misread the data. And um, you know, next time I come on, I’ll walk you through Dr. Chandler’s latest report, which shows that even Pfizer knew in their own records, that women were sustaining 75% of the adverse events and of those 16% were what Pfizer called reproductive disorders, female reproductive disorders. So Pfizer was lying. The FDA saw every one of these pages, the FDA was lying. And so everyone up and down the chain of command in our HHS and in our health system was lying to pregnant. Women. ACOG must have been lying. The, you know, the, the licensing boards, the gynecologist boards. So, um, I, there’s no way to mistreat the data. The data are clear that women are being hurt. Okay. They’re right here on my phone. They’re right there on dairy cup. They’re any place?

Steve Bannon: (06:58)

Hang on. We’re we’re we’re gonna have you back on the 10 o’clock show. We’re working your schedule. Just last thing. I’ve only got 30 seconds. They just booted out 22 cadets or mid shipment at the coast guard academy. I think today I think a few of those women, how is this in 30 seconds? How is this still going on? If, if, if this is so is this is so cut and dry Naomi Wolf,

Dr. Naomi Wolf: (07:19)

Well, you know my answer, but I’ll just keep saying it because everything I’ve told you all you know is true. Um, and if, if, if we ever make a mistake, we correct it immediately. But look at the massive 37 reports, they all are true. And what I’ve warned you about for months is true. It doesn’t make sense as medicine. It makes sense. As warfare, these female cadets are being targeted. Our military is being targeted. It is a, you know, these injections do things to, to the female 360 degree reproductive system that can’t

Steve Bannon: (07:52)

Done. Naomi, we’ll get it’s war. We’ll get to the bar. Give how did, how do people, how do people get to daily clout real quickly

Dr. Naomi Wolf: (08:00)

Go to DailyClout.io and you’ll see all 37 reports there. You’ll see the latest by Dr. Chandler showing this damage.

_________________

Pfizer Recategorized Miscarriages as “Recovered or Resolved” Adverse Events

For more:

Congenital Lyme Part 1 & 2

http://  Approx. 5 Min

Congenital Lyme Part 1

http://  Approx. 5 Min

Congenital Lyme Part 2

First-hand experiences of diagnostic challenges from the mothers whose children are impacted by Congenital Lyme Disease.

Congenital Lyme has been denied and ignored by public health ‘authorities’ for decades. They recently had to admit it happens, although per usual they state it’s “rare,” which is frankly impossible for them to know because nobody’s keeping track of it.  Why on earth are patients and advocates still crying for more federal funding for an organization that lies, suppresses, deletes, & manipulates data, and is in frank denial of a very real disease that is increasing by the day, and causes untold suffering, but then quietly updates information in the dark without any public announcement because they are conducting damage control?

Defund the CDC!

FDA Buries Head in Sand as 44% of Pregnant Trial Participants Suffer Miscarriages – Then Has the Audacity to Re-categorize Them As “Recovered” Adverse Events

https://rumble.com/v1g5nmf-pfizer-buried-their-heads-in-the-sand-as-44-of-pregnant-trial-participants  Video Here (Approx. 3 Min)

44% of Pregnant Trial Participants Suffer Miscarriages

A document released under court order reveals that 44% of pregnant women participating in Pfizer’s mRNA COVID vaccine trial suffered miscarriages.

Dr. Naomi Wolf:

Over a year ago, the FDA received this report that out of 50 pregnant women, 22 of them lost their babies, and they did not say anything. Thus the FDA was aware of the horrifying rate of fetal death by the start of April 2021 and were silent.”

“If you extrapolate, globally, to all the pregnant women who are injected, it could explain what we’re seeing now of a baby die-off.”

https://rumble.com/v1g5qnt-the-monsters-at-pfizer-recategorized-miscarriages-as-resolved-or-recovered  Video Here (Approx. 1.5 min)

Pfizer Recategorized Miscarriages as “Recovered or Resolved” Adverse Events

Dr. Naomi Wolf:

“Pfizer notes the miscarriages as serious adverse events with moderate or severe toxicity ratings. However, all of them were recategorized, by Pfizer, in the internal documents under the category of adverse events that were ‘recovered’ or ‘resolved.’

The miscarriage is in the same category as a headache that went away. If you lost your baby, Pfizer said, ‘Your adverse event was recovered or resolved.'”

____________________

**Comment**

Remember, the FDA wanted 75 years to release this information, but thanks to a non-profit who sued, a judge has ordered the agency to release 12,000 documents immediately, and then 55,000 pages a month until all documents are released — totaling more than 300,000 pages.

Predictably, Pfizer has stated that deaths in trial participants are “not related” to the ‘vaccine.’ #ABV

They have purposely been obscure and have buried the data making it very difficult to find, but scores of volunteers are pouring through the mountain of documents to unearth the unfathomable.  The icing on the cake is when Pfizer asked the court to dismiss a whistleblower lawsuit because the government was aware of the fraud.  Yes, you read that correctly.  Our government’s collusion with Big Pharma is that blatant.

Now, since data evidently doesn’t even matter, the FDA has waived clinical trials altogether for boosters.  Why even bother?

Please read Dr. Wolf’s Substack article: “Dear Friends, Sorry to Announce a Genocide” where she points out the lies:

  • FDA and Pfizer knew by Dec. 2020 that the mRNA shots waned in efficacy, presented “vaccine failure”, and that a side effect was infection with COVID
  • Pfizer knew by May 2021 that minors can experience heart damage a week after the shot, but the FDA rolled out the jab for teens anyway and parents didn’t receive a press release until August – after thousands were already “vaccinated.”
  • Pfizer knew that the spike protein and the lipid nanoparticles do not stay at the injection site but go directly into the bloodstream and then lodge in the liver, spleen adrenals, lymph nodes, testes, and ovaries.
  • The FDA knew that the Moderna shot has more than three times the 30mcg of the adult Pfizer dose of lipid nanoparticles and spike protein.
    • Pfizer knew there was a higher rate of adverse events with the 100mcg dose so they stopped experimenting with it internally due to its “reactogenicity” but nobody bothered to tell the American people who got the first and second 100mcg Moderna dose AND boosters.
    • Pfizer not only lost hundreds of records of trial subjects but chose females for 3/4 of the subjects because they are less prone to cardiac damage.
    • There were over 42,000 adverse events and more than 1,200 people DIED. Four died on the day they were injected.
    • The FDA and Pfizer knew about blistering, rashes, shingles, and herpetic conditions (blistering conditions oddly foreshadowing monkeypox symptoms)
    • The shots contain PEG, an allergen that causes some to go into anaphylactic shock but nobody, especially those with a PEG allergy, was warned or even watched by their doctor
    • Pfizer’s documents show that “exposure” to the ‘vaccine’ was defined as sexual and skin contact, inhalation, or via lactation.
    • Pfizer BioNTech’s SEC filing shows a fainting side effect so violent you may hurt yourself.  Please consider this when you hear of people “slipping and falling” and hitting their heads.  #ABV

For more:

Lyme & Pregnancy

https://lymediseaseassociation.org/blogs/lda-guest-blogs/sue-faber-rn-bscn-guest-blog-lyme-pregnancy/

Sue Faber, RN, BScN Guest Blog – Lyme & Pregnancy

SueFaberbyStef&Ethan

Sue Faber is a Registered Nurse (BScN) and Co-founder and President of LymeHope, a not-for-profit organization in Canada.  Sue’s specific area of expertise and research is in the compilation and analysis of the literature that exists on maternal-fetal transmission of Lyme and congenital Lyme borreliosis; amplifying, supporting and powering urgent research initiatives to investigate this alternate mode of transmission with the ultimate goal of opening new doors to ensure that children and families affected are able to access appropriate care, treatment, and support.

In 2018, Sue co-authored a nursing resolution for the Registered Nurses Association of Ontario – based on the needs and voiced concerns of Canadians  with Lyme disease coast to coast.  ‘Patient First Treatment for Ontarians with Lyme Disease’– which was passed at the annual 2018 AGM in Toronto.    Sue was awarded the RNAO HUB Fellowship award in 2019.  Sue is honored to be an advisor to the newly formed advocacy group Mothers Against Lyme and has spoken at various conferences on maternal-fetal transmission of Lyme including ILADS (2019), LymeMIND (2019, 2020), NE Ohio Lyme Symposium,  Lyme WNY Symposium and Target Lyme (Ontario).   Sue is honored to collaborate with colleagues from McMaster Midwifery Research Centre in new ground-breaking research on Lyme and Pregnancy.

Sue is firmly committed to transparent and collaborative partnerships with governments, academia, research institutions, healthcare colleagues, and industry stakeholders, to collectively identify challenges, knowledge gaps, and fresh opportunities, to examine and develop transformative health policy, best practice guidelines, and research priorities, which are anchored in patient voice, values, and priorities.

Lyme and Pregnancy:  A Hopeful and Tangible Path Forward

My History  I’ll never forget the day at the end of January 2017 that I received an official letter from my local public health department.  The letter was in response to my requests for a meeting with senior management, to alert them to positive test results for Lyme disease for both myself and one of my daughters and to discuss my concerns that I may have transmitted this infection to her in-utero.   A year earlier I had tested two-tier positive for a European strain of Lyme in Canada – after years of complex multi-system medical symptoms which were fully investigated by multiple medical specialists, without any definitive answers.   I had no recall of a tick bite or an erythema migrans rash and thus tickborne disease had never been considered as a differential diagnosis by my medical team.  As a trained ER nurse, I knew nothing about Lyme disease.

It was a stroke of luck that my primary doctor decided to test me for Lyme after every other possible diagnosis had been ruled out.  The test was positive. My eventual diagnosis of late-stage disseminated Lyme disease by a Canadian infectious disease physician was initially a relief as I now had a name to my illness and what I thought would be a defined path to recovery and healing.  Little did I know that this diagnosis would be the start of a journey into advocacy – one which I have likened to climbing up a steep mountain – without a map or guide – trusting and hoping that one day, I’d make it to the top.

As a Registered Nurse I am extensively trained in evidence-based practice and problem-based learning which has put me in good stead after receiving my Lyme disease diagnosis. I started delving into the published literature on Lyme disease and soon discovered the multi-system complexities of Lyme disease with some researchers identifying striking similarities to syphilis. [i] [ii]  Soon thereafter, I discovered the first published case report that Lyme disease could be transmitted from a mother to her baby in-utero in a paper titled ‘Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi’.[iii]  My heart started to race, I was nauseated and tears started to fall down my cheeks – could this mean that my precious daughters were also impacted?   Like most other aspects of Lyme, I would soon learn that the issue of maternal-fetal transmission was very controversial.

The onset of my symptoms was gradual and predated all of my pregnancies including one first trimester pregnancy loss.  All my daughters had struggled with varying complex medical issues from birth which included jaundice, severe colic, high fevers, myocarditis, atypical seizures, severe OCD, night terrors, anxiety, joint pain, learning difficulties, abdominal pain, strange rashes, speech delay, severe headaches, frequent pneumonia and double vision.  Each child had different clinical manifestations with one common theme – there were no definitive answers as to why.  Could tickborne infection transmitted in-utero be contributing to their illnesses?

My infectious disease physician who was treating me at the time never mentioned that Lyme could be transmitted in pregnancy. Later after I asked, they acknowledged that yes, there were case reports.  One of my daughters also tested two-tier positive in Canada for a European strain of Lyme disease – except unlike me who had lived in Asia and travelled throughout Europe where European strains of Lyme are predominant, she hadn’t.  We both had positive tests for a European strain of Lyme disease and this was why I had asked for a meeting with my local public health unit.  I was hoping they would be interested in investigating the possibility of maternal-fetal transmission.

Instead, the letter I received back was disheartening and disconcerting.  I was advised that despite having tested positive in Canada, using two-tier criteria, both our cases would not be counted in Canadian surveillance statistics because our symptoms were ‘non-specific’ and we didn’t have a ‘clear onset’ or ‘reliable travel history.’  Furthermore I was informed that they had completed ‘a significant amount of research and no scientific evidence to support congenital Lyme in the scientific literature was found.’

—————————————–

Starting a Non-Profit: LymeHope  By this time, I had read more primary research papers reporting transmission of Lyme from mother to baby in-utero [iv] [v] including a report issued by the World Health Organization[vi] and Health and Welfare Canada[vii] clearly documenting the risk of this alternate mode of transmission and possible adverse pregnancy outcomes.  Shortly thereafter, myself and colleague Jennifer Kravis co-founded the Canadian not-for-profit organization LymeHope.[viii]

In February 2017, we started a ‘Ticking Lyme Bomb’ petition[ix] which now has over 86,600 signatures and over 17,000 personal comments from across Canada.  We also arranged meetings with Federal politicians from all parties, organized a bi-partisan round-table in Ottawa on Lyme disease,[x] testified at a Parliamentary Health Committee hearing[xi] and met with senior executives, scientists and officials from the Public Health Agency of Canada and Health Canada.  We were invited to meet with then Federal Minister of Health[xii] and then leader of the Conservative Party of Canada – each time drawing attention to the many complex, serious issues faced by Lyme sufferers across Canada including the documented risk of maternal-fetal transmission.  Each meeting represented another step ‘up the mountain’ with goals of identifying and initiating meaningful, collaborative solutions including innovative research – anchored in meaningful patient engagement and triaged by patient priorities.

In 2018 I co-authored a resolution on Lyme disease which was passed by the Registered Nurses Association of Ontario (RNAO) membership titled: ‘Patient First Treatment for Ontarians with Lyme Disease.’ [xiii]  This resolution highlights the multi-faceted issues faced by Canadian Lyme sufferers and the RNAO would later feature our resolution in an article[xiv] in their Registered Nurse Journal. I am so grateful for the ongoing support of the RNAO and especially the brilliant leadership of Dr. Doris Grinspun who leads the organization.  I’ll never forget her addressing the RNAO membership at the 2018 Annual General Meeting in Toronto – this was the meeting in which our resolution was later being presented for vote.  She shared in general terms that ‘disruption’  may be necessary when confronting obstacles which stand in the way of Canadians accessing appropriate health care.   As she spoke, tears flowed down my cheeks as I recalled the numerous letters, petition comments, personal testimonies and cries for help from my fellow Canadians – adults[xv] and children[xvi] alike – struggling to access appropriate care[xvii] and treatment for Lyme disease within Canada.[xviii]

I personally didn’t want to be labeled as a ‘disruptor’ but rather a bridge-builder and peace-maker.  I so badly wanted meaningful, sustainable change for Canadians with Lyme disease.  However, I have since learned that ‘disruption’ is sometimes necessary if it leads to re-calibration, innovation and opens new opportunities for critical thinking, trust-building, identifying strategic research initiatives and initiates forward momentum.  Many issues around Lyme disease urgently need re-investigation including adequate testing, treatment and alternate modes of transmission.  New research continues to emerge which challenges the status quo, such as the persistence of the Lyme spirochete despite antibiotic treatment.[xix]  [xx]  This is an issue which advocates, clinicians and scientists have identified for decades and is anchored in findings from hundreds of peer-reviewed papers.[xxi]  What is most important is that new research on Lyme disease must be patient relevant.  In a 2016 CMAJ editorial article by Kristen Patrick[xxii], she states, ‘For patient-relevant research to be meaningful, patient and public engagement in research cannot comprise a token lay person on a research ethics review board.  Patients and their caregivers must be involved in decision-making at all steps in the research process, from design, to choice of primary and secondary outcomes, through dissemination and implementation.’

——————————————

National Media Coverage  In 2019, CTV National News[xxiii] highlighted our advocacy work regarding maternal-fetal transmission of Lyme disease and the importance of initiating new research collaborations on this important, under-studied issue.  This national media coverage also highlighted a systematic review on gestational Lyme[xxiv] which had been authored by scientists from both the Public Health Agency of Canada and CDC.  This review included a meta-analysis which identified a significant difference in the frequency of adverse outcomes between treated and untreated pregnancies affected by Lyme disease.

In 2020, an advocate shared with me a discovery that three Federal Canadian agencies including: Health Canada[xxv], Public Health Agency of Canada[xxvi] and Occupational Health and Safety Canada,[xxvii] had historically acknowledged the risk of adverse outcomes associated with Lyme and pregnancy and/or maternal fetal transmission of Lyme on their respective websites.  In all three cases, over a period of several years, this precautionary guidance was subsequently removed.   For years,  we had been advocating for acknowledgement of these issues which had already been publicly communicated!

——————————————

20 Years of Research Has Not Overturned Published Risks & Adverse Outcomes  As there has been no new research in over 20 years which has negated, questioned or overturned the published findings of earlier investigators, these precautionary statements should be clearly communicated.  This is highlighted by the tenants of the Precautionary Principle and clearly communicated in a Health Canada Framework on Managing Health Risks which states: [xxviii] ‘A key feature of managing health risks is that decisions are often made in the presence of considerable scientific uncertainty. A precautionary approach to decision making emphasizes the need to take timely and appropriately preventative action, even in the absence of a full scientific demonstration of cause and effect.’ Both the public and healthcare practitioners should be made aware of these documented risks of adverse pregnancy outcomes and of in-utero transmission of Lyme itself, even if considered rare.  I have asked Canadian Public Health Agency officials for rationale as to why this guidance was removed and continue to await an evidence-based response.

I trust that the Public Health Agency of Canada and Health Canada will follow the CDC[xxix] and NIH[xxx] in updating their public guidance on Lyme and pregnancy to acknowledge that YES, Lyme can be transmitted in utero.  With this simple, evidence-based acknowledgement as a starting point – new doors WILL open for urgent, multi-disciplinary research to better understand this alternate mode of transmission and open new avenues for families and children impacted to receive the medical care and support they need and deserve.

——————————————

So where do we go from here?  There is action, HOPE and meaningful forward momentum!  In Canada, a brand new research project on Lyme and Pregnancy was initiated in the fall of 2020 by McMaster University Midwifery Research Centre[xxxi] and remains open for participants from the US, Canada and globally, I am thankful to part of this research team.  The Canadian Association of Schools of Nursing (CASN) has just released free, open access, online resources including online learning modules for nurses and other professionals working with clients, communities and populations facing climate-driven infectious diseases.[xxxii]  This innovative resource acknowledges both the risk of maternal-fetal transmission of Lyme disease and potential for adverse pregnancy outcomes and also includes a section titled: ‘Living with Climate-Driven Vector-Borne Disease’ which highlights patient advocacy efforts, patient stories and patient centered resources.[xxxiii]  I am so proud that nurses are listening, engaging and paving an inclusive way forward which respects, empowers and includes patients.

In the US, the Cohen Foundation[xxxiv] continues to lead with generous philanthropy for Lyme disease research, innovation and collaboration.  For the last two years I have been honored to represent LymeHope as a panelist in the  LymeMind Conference[xxxv], speaking directly to the issue of maternal-fetal transmission of Lyme[xxxvi] and alongside other experts, bringing this important, understudied alternate mode of transmission back into the forefront of academia and government.  I recently spoke at a webinar hosted by Project Lyme and Mothers Against Lyme Disease [xxxvii] where I shared an overview of the literature on Lyme and Pregnancy[xxxviii]  and also shared several research recommendations for a path forward.

The recent US HHS announcement of LymeX, in partnership with the Steven and Alexandra Cohen Foundation[xxxix] is an extraordinary step forward in bringing together diverse stakeholders including government, non-profits, academia, advocates, patients and industry to ‘accelerate Lyme innovation.’  A recent Notice of Special Interest by the NIH for improving outcomes for maternal health[xl] included ‘development and validation of diagnostics for gestational Lyme disease, which can adversely impact maternal health and pregnancy outcomes.’  All of these things are indicators of positive forward momentum and provide me with renewed Hope that new science, innovation and collaboration will lead the way and open new doors.

Four years after starting Lyme advocacy I believe that we are collectively reaching a Lyme tipping point and patients and advocates are being respected, welcomed and heard.  I admit, there have been times I have been discouraged, exhausted, frustrated and even wanted to step away from leadership.  I’m so thankful for many who encourage me to keep going.  Advocacy in a field as contentious as Lyme disease can be a lonely, misunderstood place.  Pushing for change can be met with skepticism and silence.   If we continue to take one step and another, anchored in evidence, leaning on scientific inquiry and partnered with respectful dialogue and meaningful collaboration – we will make it up to the top of the mountain.

I really look forward to the view from the top of the mountain and one day reaching the pinnacle and planting a flag which represents the hard work and dedication of advocates, patients, scientists, researchers, not-for-profits, clinicians and government officials – all determined to make a lasting difference on behalf of Lyme sufferers . For all the families impacted by Lyme disease and those concerned that in-utero transmission may be a factor in their child’s illness – don’t give up!  I wish I could give you a big Mama-bear hug – we must keep speaking out and sharing our stories, concerns and ideas for solutions.  Our collective voice is being heard and acknowledged and I truly believe that help is on the way.


Footnotes

[i] Hercogova J, Vanousova D. Syphilis and borreliosis during pregnancy. Dermatol Ther. 2008 May-Jun;21(3):205-9. doi: 10.1111/j.1529-8019.2008.00192.x. PMID: 18564251.

[ii] Miklossy, J. (2008). Biology and Neuropathology of Dementia in Syphilis and Lyme Disease. Handbook of Clinical Neurology, 825–844. doi:10.1016/s0072-9752(07)01272-9

[iii] Schlesinger PA, Duray PH, Burke BA, Steere AC, Stillman MT. Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi. Ann Intern Med. 1985 Jul;103(1):67-8. doi: 10.7326/0003-4819-103-1-67. PMID: 4003991.

[iv] Weber K, Bratzke HJ, Neubert U, Wilske B, Duray PH. Borrelia burgdorferi in a newborn despite oral penicillin for Lyme borreliosis during pregnancy. Pediatr Infect Dis J. 1988 Apr;7(4):286-9. doi: 10.1097/00006454-198804000-00010. PMID: 3130607.

[v] MacDonald AB. Gestational Lyme borreliosis. Implications for the fetus. Rheum Dis Clin North Am. 1989 Nov;15(4):657-77. PMID: 2685924.

[vi] World Health Organization, Geneva. Weekly Epidemiological Record. No. 39. 26 September 1986. Page 297-304.

[vii] Health and Welfare Canada. Lyme Disease in Canada. Canada Dis Wkly Report, June 4, 1988.

[viii] LymeHope:  https://www.lymehope.ca/

[ix] Ticking Lyme Bomb Petition: https://www.change.org/p/minister-philpott-ticking-lyme-bomb-in-canada-fix-canada-s-lyme-action-plan-now

[x] MP Round Table and MP engagement.  https://www.lymehope.ca/advocacy-updates/update-on-mp-round-table-and-mp-engagement-regarding-lyme-disease-in-canada

[xi] Standing Committee on Health, Tuesday, June 6th, 2017.  Evidence. https://www.ourcommons.ca/DocumentViewer/en/42-1/HESA/meeting-59/evidence

[xii] Kingston, Anne.  How the Impatient Patient is Disrupting Medicine.  Macleans Magazine,  Oct, 2017. https://www.macleans.ca/society/health/how-the-new-impatient-patient-is-disrupting-medicine/

[xiii]https://myrnao.ca/sites/default/files/attached_files/Resolution%202018%20Final%20from%20AGM%20with%20amendments%20for%20website.pdf

[xiv]Registered Nurses Association of Ontario. ‘Ticking Lyme Bomb, May/June 2018. https://rnao.ca/sites/rnao-ca/files/RNJ-MayJune2018_ticking_lyme_bomb.pdf

[xv]Patient Testimonies at 2016 Federal Framework on Lyme Disease. https://www.canada.ca/en/public-health/services/diseases/lyme-disease/federal-framework-lyme-disease-conference/audio-recordings/public-forum-1.html

[xvi] Stimers, Daniel. Lyme Disease MP Roundtable Address, May 2018.  https://www.youtube.com/watch?v=Td-Vw-V7kGU&feature=youtu.be

[xvii] Gaudet EM, Gould ON, Lloyd V.  Parenting When Children Have Lyme Disease:  Fear, Frustration, Advocacy.  Healthcare 2019, 7(3), 95: https://doi.org/10.3390/healthcare7030095

[xviii] Boudreau CR, Lloyd VK, Gould ON. Motivations and Experiences of Canadians Seeking Treatment for Lyme Disease Outside of the Conventional Canadian Health-Care System. J Patient Exp. 2018;5(2):120-126. doi:10.1177/2374373517736385

[xix] Sapi E, Kasliwala RS, Ismail H, Torres JP, Oldakowski M, Markland S, Gaur G, Melillo A, Eisendle K, Liegner KB, Libien J, Goldman JE. The Long-Term Persistence of Borrelia burgdorferi Antigens and DNA in the Tissues of a Patient with Lyme Disease. Antibiotics (Basel). 2019 Oct 11;8(4):183. doi: 10.3390/antibiotics8040183. PMID: 31614557; PMCID: PMC6963883.

[xx] https://news.tulane.edu/pr/study-finds-evidence-persistent-lyme-infection-brain-despite-aggressive-antibiotic-therapy; https://www.frontiersin.org/articles/10.3389/fneur.2021.628045/full

[xxi]Peer-Reviewed Evidence of Persistence of Lyme Disease Spirochete Borrelia burgdorferi and Tick-Borne Diseases https://www.ilads.org/wp-content/uploads/2018/07/CLDList-ILADS.pdf

[xxii] Patrick, K. Realizing the Vision of Patient Relevant Research. CMAJ, Vol 188, Issue 15, Oct 2016. https://www.cmaj.ca/content/188/15/1063.full

[xxiii] CTV National News.  Mothers on a mission to prove Lyme disease can be passed to an unborn child. https://www.ctvnews.ca/health/mothers-on-a-mission-to-prove-lyme-disease-can-be-passed-to-unborn-child-1.4261403

[xxiv] Waddell LA, Greig J, Lindsay LR, Hinckley AF, Ogden NH (2018) A systematic review on the impact of gestational Lyme disease in humans on the fetus and newborn. PLoS ONE 13(11): e0207067. https://doi.org/10.1371/journal.pone.0207067

[xxv] Health Canada. (October 2006) https://web.archive.org/web/20061018070947/http:/www.hc-sc.gc.ca/iyh-vsv/diseases-maladies/lyme_e.html

[xxvi] Public Health Agency of Canada (March 2009)

https://web.archive.org/web/20090307034620/http:/www.phac-aspc.gc.ca/id-mi/lyme-fs-eng.php

[xxvii]Canadian Centre for Occupational Health and Safety (May 1999)

https://web.archive.org/web/19990508215316/http:/www.ccohs.ca/oshanswers/diseases/lyme.html

[xxviii] Health Canada Decision making framework identifying, assessing and managing health risks, August 1, 2000: https://www.canada.ca/en/health-canada/corporate/about-health-canada/reports-publications/health-products-food-branch/health-canada-decision-making-framework-identifying-assessing-managing-health-risks.html#a13

[xxix] CDC. Pregnancy and Lyme Disease: https://www.cdc.gov/lyme/resources/toolkit/factsheets/Pregnancy-and-Lyme-Disease-508.pdf

[xxx] Lyme Disease, the Facts, the Challenge. NIH Publication No. 08-7045.  2008.

https://permanent.fdlp.gov/lps81243/LymeDisease.pdf

[xxxi] McMaster University Midwifery Research Centre.  ‘Health Outcomes of people with Lyme disease during pregnancy.’

English Version:  https://obsgynresearch.mcmaster.ca/surveys/index.php?s=MN9CCXDTW9

French Version: https://obsgynresearch.mcmaster.ca/surveys/?s=KWJT9K9TR9

[xxxii] Canadian Association of Schools of Nursing. Nursing and Climate Driven Vector Borne Disease.  https://vbd.casn.ca/

[xxxiii] Canadian Association of Schools of Nursing. Living with Climate Driven Vector Borne Disease. https://vbd.casn.ca/index.php/resources/living-with-climate-driven-vector-borne-disease/

[xxxiv] Cohen Lyme and Tickborne Disease Initiative:  https://www.steveandalex.org/ticks-suck/

[xxxv] LymeMIND: https://lymemind.org/

[xxxvi] 5th Annual LymeMIND Virtual Conference 2020: Mothers and Children Panel. https://www.youtube.com/watch?v=gevtoKkzS2Y&t=8s

[xxxvii] https://lymediseaseassociation.org/about-lyme/pregnancy-and-lyme/lyme-disease-pregnancy-research-opportunities-webinar/

[xxxviii] https://lymediseaseassociation.org/wp-content/uploads/2021/05/SueFaber_Maternal-Fetal-Transmission-of-Lyme-Research-Gaps-and-Next-Steps_April-29-2021_Webinar.pdf

[xxxix] LymeX initiative: https://www.hhs.gov/cto/initiatives/innovation-and-partnerships/lyme-innovation/lymex/index.html

[xl] Notice of Special Interest (NOSI): Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health

https://grants.nih.gov/grants/guide/notice-files/NOT-EB-21-001.html

Congenital Lyme & the NIH

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/30349687

Congenital Lyme and the NIH

Carl Tuttle

Hudson, NH, United States

Mar 19, 2022 — 

Latest email sent to the Tick-Borne Disease Working Group…

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “Dennis.Dixon1@nih.hhs.gov” <Dennis.Dixon1@nih.hhs.gov>, “SSood@nshs.edu” <SSood@nshs.edu>
Cc: “tickbornedisease@hhs.gov” <tickbornedisease@hhs.gov>
(all members of the TBDWG)
Date: 03/19/2022 8:34 AM
Subject: Congress Commends NIH Collaboration with Advocacy Groups to Advance Research on Maternal-Fetal Transmission of Lyme Disease


To the Tick-Borne Disease Working Group,

Please see the news release below regarding congenital Lyme and the NIH.

Congenital Lyme was first identified in 1985 (Allen Steere) per the attached lengthy list of references and yet it took 37 years for the NIH to acknowledge this evidence? Isn’t this a crystal clear indication that our Public Health Agencies are COMPLETELY BROKEN!!

Congenital Lyme References
https://www.dropbox.com/s/g5am2pamxc1a4hx/Congenital%20Transmission%20of%20Lyme.doc?dl=0

We have autopsy results and a lengthy list of references proving chronic Lyme as well and that too is going unrecognized by members Dixon and Sood on this Working Group. Isn’t this a crystal clear indication that our Public Health representatives are COMPLETELY BROKEN!!

Announcement from Bruce Fries, President, Patient Centered Care Advocacy Group:

Congress Commends NIH Collaboration with Advocacy Groups to Advance Research on Maternal-Fetal Transmission of Lyme Disease (Please read this article!!)
https://www.webwire.com/ViewPressRel.asp?aId=284113

Note from Bruce Fries:

Since NIH has a history of noncompliance with appropriations directives for Lyme, the release includes language to hold them accountable. Success will be determined by the amount of grants funded that have measurable benefits for mothers and children.

Much of the long-term follow-up will be addressing the bias in the NIH special study sections that prevents grants from being approved for research that might challenge the mainstream dogma. Rather than calling the baby ugly, I think a better approach may be to push for creation of a special study section that focuses on tick-borne diseases and make sure the nomination and selection processes are open and transparent.

Many thanks to the advocates and advocacy groups who helped make this happen.

Bruce Fries
​President, Patient Centered Care Advocacy Group
Advisor for Research and Public Policy, Mothers Against Lyme
202-617-1592

BruceFries@Gmail.com

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u

Congenital Lyme and the NIH Part 2

Carl Tuttle

Hudson, NH, United States

Mar 21, 2022 — 

Please see the message below sent to the attention of Becky Salay, Chief-of-Staff for Congresswoman Rosa DeLauro. If you agree with my assessment why not send your comments to becky.salay@mail.house.gov referencing this petition update.

———- Original Message ———-

From: CARL TUTTLE <runagain@comcast.net>
To: “becky.salay@mail.house.gov” <becky.salay@mail.house.gov>, “caitlin.peruccio@mail.house.gov” <caitlin.peruccio@mail.house.gov>, “info@tfah.org” <info@tfah.org>,
Cc: All members of the Tick-Borne Disease Working Group
Date: 03/20/2022 10:34 AM
Subject: Re: Congress Commends NIH Collaboration with Advocacy Groups to Advance Research on Maternal-Fetal Transmission of Lyme Disease

DEPARTMENTS OF LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION, AND RELATED AGENCIES APPROPRIATIONS BILL, 2022
https://docs.house.gov/meetings/AP/AP00/20210715/113908/HMKP-117-AP00-20210715-SD003.pdf

Mar 20, 2022

2413 Rayburn House Office Building
Washington, DC 20515
Attn: Congresswoman Rosa DeLauro, Congenital Lyme and the NIH

Dear Rep DeLauro,

Please take a moment to read the following email thread and attachment addressed to the Federal Tick-Borne Disease Working Group. From the announcement below, the 2022 appropriations bill for the NIH signed into law on March 15 requires the NIH to advance research on maternal-fetal transmission of Lyme disease.

Maternal-fetal transmission of Lyme disease was identified in 1985 and it has taken 27 years for our Public Health Officials to recognize and investigate only after an act of congress?

Congenital Transmission of Lyme (personal Dropbox storage area)
https://www.dropbox.com/s/g5am2pamxc1a4hx/Congenital%20Transmission%20of%20Lyme.doc?dl=0

As you will read below, congenital Lyme is only the tip of the iceberg as chronic infection after extensive antibiotic treatment has been verified through autopsy studies. What does this mean? We have been dealing with an antibiotic resistant/tolerant superbug denied by the same Public Health Officials who have suppressed evidence of congenital Lyme for twenty-seven years!

Patient testimony all across America is describing a disease that is destroying lives, ending careers while leaving its victim in financial ruin. Read the Written Public Comments published with each of the Working Group’s meetings to gain an understanding of the suffering. No matter how many of these comments are documented, no matter how many studies identifying persistent infection, the Federal representatives and past co-chair of this Working Group refer to chronic Lyme as a “religious belief.”

Written Public Comments
https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/index.html

Chronic Lyme as a “religious belief” [Dr. David Walker]
https://www.lymedisease.org/tuttle-comment-tbdwg-nov17/

Quote from Senator Richard Blumenthal: (2011)!!!

“Today for me culminates more than a decade of work and probably a decade more, because I’ve seen firsthand the devastating, absolutely unacceptable damage done by Lyme disease to individual human beings, Connecticut children and residents whose lives have been changed forever as a result of Lyme disease”  Source: http://ctmirror.org/2011/07/18/blumenthal-takes-lyme-disease-fight-senate/

It is time to put an end to this Medical Mafia suppressing scientific evidence (for the purpose of controlling the narrative) and find a cure for this antibiotic resistant/tolerant superbug. Those of us who have studied the mishandling of Lyme disease are convinced that the rush to create a vaccine (LYMErix) is the root cause because a chronic relapsing seronegative disease did not fit the vaccine model. The FDA has fast-tracked a Lyme disease vaccine while this Working Group is in session; a vaccine for a disease that the IDSA describes as “Hard to Catch and Easily Treated” with 2-4 weeks of antibiotics.

So what is the message I’m trying to convey here? You or a loved one (and everyone else reading this message) is a single tick bite away from experiencing this travesty. One more important question Rep Delauro; How much Lyme disease is in America’s blood supply??

A response to this inquiry is requested.

Respectfully submitted,

Carl Tuttle
Hudson, NH

Cc: Rebecca Salay, MSc Chief of Staff (Please forward to Rep DeLauro)

Member of Gov Chris Sununu’s Lyme Disease Study Commission
https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/30346445

Correspondence sent to the Tick-Borne Disease Working Group:

PETITION UPDATE
Congenital Lyme and the NIH
https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/30349687

PETITION UPDATE
HB490 COMMISSION TO STUDY TESTING FOR LYME AND OTHER TICK-BORNE DISEASES
https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/30346445

PETITION UPDATE
Evidence of chronic Lyme
https://www.che through autopsy studiesange.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/30304104

Public comment: Does that sound like a religious belief, Dr. Walker?